Advertisement


Marie-Andrée Forget, PhD, on Metastatic Melanoma: Update From MD Anderson

2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Tweet this page

Marie-Andrée Forget, PhD, of The University of Texas MD Anderson Cancer Center, discusses study findings on the impact of checkpoint blockade prior to adoptive cell therapy using tumor-infiltrating lymphocytes for metastatic melanoma. (Abstract 138)

Advertisement

Advertisement



Advertisement

click me